Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Xenetic Biosciences, Inc. (XBIO) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$0.73M |
|
$-1.70M |
|
-- |
|
$0.73M |
|
$2.46M |
|
$-1.74M |
|
$0.04M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.74M |
|
$-1.74M |
|
2.34M |
|
2.34M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$6.00M |
|
-- |
|
$0.31M |
|
$6.32M |
|
$1.90M |
|
-- |
|
-- |
|
$1.90M |
|
$4.41M |
|
$4.41M |
|
$4.41M |
|
2.34M |
|
| Cash Flow Statement Financials | |
$-2.07M |
|
-- |
|
-- |
|
$7.88M |
|
$5.81M |
|
$-2.07M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.15 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-239.80% |
|
-239.80% |
|
-- |
|
-233.78% |
|
-233.78% |
|
$-2.07M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-38.41% |
|
-38.42% |
|
-26.84% |
|
-38.42% |
|
$1.88 |
|
$-0.89 |
|
$-0.89 |
|